MINNEAPOLIS, Sept. 13, 2017 (GLOBE NEWSWIRE) — Tactile Systems Technology, Inc. (“Tactile Medical” or the “Company”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the pricing of a previously announced underwritten registered offering by certain of its stockholders of 3,300,000 shares of Tactile Medical common stock at a price to the public of $33.00 per share. In connection with the offering, the selling stockholders have granted the underwriters an option to purchase up to an additional 495,000 shares. Tactile Medical will not receive any proceeds from the offering. The offering is expected to close on or about September 15, 2017, subject to satisfactory completion of customary closing conditions.
Top Entertainment
Search
New Posts
Investment in Indian Hotels Surged in 2023 – India Report
Radisson Debuts Luxury Brand in India, More New Hotels To Follow
The Keys to Luxury: Michelin Debuts New Rating System For France’s Finest Hotels
Wyndham Pushes Premium Strategy After Fending Off Choice’s Hostile Bid
Hoping for a Paris Olympics Boost? Accor Expects Only a Small Bump
Leave A Comment